CASI PHARMACEUTICALS, INC. Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)
CASI PHARMACEUTICALS, INC. (CASIF) reported Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) of -$11.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss · last filed 2026-05-15
| Period end | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 12 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$11.00K 20-F · filed 2026-05-15 | |
| 2024-12-31 | $3.00K 20-F · filed 2026-05-15 | |
| 2023-12-31 | $1.00K 20-F · filed 2026-05-15 | |
| 2022-12-31 | $1.25M 20-F · filed 2025-03-31 | -$1.25M 20-F · filed 2023-04-26 |
| 2021-12-31 | -$340.00K 20-F · filed 2024-03-28 | $340.00K 20-F · filed 2023-04-26 |
| 2020-12-31 | $825.00K 20-F · filed 2023-04-26 |